Bottom line
BPH vs RERGX: the short answer
BPH (BP p.l.c. ADRhedged) and RERGX (EUPAC Fund) are both etfs.
But RERGX is far broader, holding 398 positions to 3 for BPH, so beyond the top names it adds exposure BPH doesn't have.
BPH is cheaper at 0.19% vs 0.47% — a difference of $28 a year per $10,000 invested.
Updated Nov 19, 2026
BPH vs RERGX side by side
| BPH | RERGX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | DWS (Xtrackers) | American Funds (Capital Group) |
| Category | International Stock | International Stock |
| Expense ratio | 0.19% | 0.47% |
| Annual cost per $10k | $19 | $47 |
| 10-yr cost on $10k (prospectus) | $243 | $591 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +29.2% |
| 5-yr return (annualized) | — | +4.6% |
| 10-yr return (annualized) | — | +8.5% |
| Best quarter | — | +22.7% |
| Worst quarter | — | −22.5% |
| Net assets (fund) | $1.8M | $140.9B |
| Number of holdings | 3 | 398 |
| Portfolio turnover | % | 5% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
BPH and RERGX share none of their top holdings.
BPH top 10
- Bp Plc — 95.62%
- Dreyfus Trsry Securities — 4.58%
- Canadian Imperial Bank Of Commerce — -0.19%
RERGX top 10
- Taiwan Semiconductor Manufacturing Co Ltd — 7.44%
- Sk Hynix Inc — 5.39%
- Capital Group Central Cash Fund — 3.39%
- Asml Holding Nv — 2.41%
- Softbank Group Corp — 1.86%
- Unicredit Spa — 1.40%
- Astrazeneca Plc — 1.31%
- Cenovus Energy Inc — 1.28%
- Airbus Se — 1.26%
- Samsung Electronics Co Ltd — 1.25%
FAQ
What is the difference between BPH and RERGX?
BPH (BP p.l.c. ADRhedged) and RERGX (EUPAC Fund) are both etfs. But RERGX is far broader, holding 398 positions to 3 for BPH, so beyond the top names it adds exposure BPH doesn't have.
Which is cheaper, BPH or RERGX?
BPH has the lower expense ratio (0.19%).
Should I own both BPH and RERGX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.